Conditionally essential fatty acid deficiencies in end-stage liver disease

Nutrition

Volumn 15, Issue 4, 1999, Pages 302-304

  Burke, Peter A ^a   Ling, P R ^a   Forse, R A ^a   Bistrian, Bruce R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; End stage liver disease; Essential fatty acids; Polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL ESTER; DOCOSAHEXAENOIC ACID; ENZYME; ESSENTIAL FATTY ACID; FISH OIL; ICOSANOID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; LIPID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

DIET; ENZYME ACTIVITY; ESSENTIAL FATTY ACID DEFICIENCY; HUMAN; LIVER BIOPSY; LIVER FAILURE; PRIORITY JOURNAL; REVIEW;

ALPHA-LINOLENIC ACID; ENERGY INTAKE; FATTY ACIDS, ESSENTIAL; FATTY ACIDS, UNSATURATED; HUMANS; LINOLEIC ACID; LIVER DISEASES;

EID: 0032927285     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(99)00002-7     Document Type: Review

References (15)

1. Cabre E., Gassull M.A. Polyunsaturated fatty acid deficiency in liver diseases pathophysiological and clinical significance . Nutrition. 12:1996;542.
2. Gonzalez J., Periago J.L., Gil A., et al. Malnutrition-related polyunsaturated fatty acid changes in plasma lipid fraction of cirrhotic patients. Metabolism. 41:1992;954.
3. Palombo J.D., Lopes S.M., Jenkins R.L., et al. Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end stage liver disease. Gastroenterology. 93:1987;1170.
4. Rimola A., Gines P., Cuso E., et al. Prostaglandin precursor fatty acids in cirrhosis with ascites effect of linoleic acid infusion in functional renal failure . Clin Sci. 74:1988;613.
5. James P., Norman K., Rosenberg I. The nutrition of fat. Meeting summary. Nutr Rev. 50:1992;68.
6. Spielmann D. Metabolism of unsaturated fatty acids role of n-3 and n-6 fatty acids in clinical nutrition. Kinney J.M., Borum P.R. Perspectives in clinical nutrition. 1989;351 Urban and Schwarzenberg, Munich.
7. Cabre E., Periago J.L., Gonzalez J., et al. Plasma polyunsaturated fatty acids in liver cirrhosis with or without chronic hepatic encephalopathy a preliminary study . JPEN. 16:1992;359.
8. Cabre E., Periago J.L., Gonzalez J., et al. Plasma fatty acid profile in advanced cirrhosis unsaturation deficit of lipid fractions . Am J Gastroenterol. 85:1990;1597.
9. French S.W., Morimoto M., Reitz R.C., et al. Lipid peroxidation, CYP2E1 and arachidonic acid metabolism in alcoholic liver disease in rats. J Nutr. 127:1997;907S.
10. Daikh B.E., Lasker J.M., Raucy J.L., Koop D.R. Regio and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther. 27:1994;1427.
11. Carlson S.E., Werkman S.H., Tokey E.A. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. Am J Clin Nutr. 63:1996;687.
12. Cabre E., Abad Lacruz A., Nunez M.C., et al. The relationship of plasma polyunsaturated fatty acid deficiency with survival in advanced liver cirrhosis, multivariate analysis. Am J Gastroenterol. 88:1993;718.
13. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 120:1992;S129.
14. Goheen S.C., Larkin E.C., Rao G.A. Severe fatty liver in rats fed a fat-free ethanol diet and its prevention by small amounts of dietary arachidonate. Lipids. 18:1983;285.
15. Ling P.R., Boyce P., Bistrian B.R. Role of arachidonic acid in the regulation of the inflammatory response in TNF-treated rats. JPEN. 22:1998;S1.